PRINCETON, NJ. – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling stockholders are offering 9,760,000 shares of common stock in […]
Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer […]
Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Dr. Muthu Meyyappan as Chief Commercial Officer (CCO), effective immediately. Muthu will lead all aspects of Congenica’s sales and marketing and will be based in Boston, MA. […]
ST. LOUIS & SAN DIEGO — PierianDx, the leading clinical genomics informatics company, and Bench International, a leading global executive search firm, jointly announce the appointment of Mark McDonough as Chief Executive Officer (CEO) and member of the Board of Directors of PierianDx, effective immediately. In his new role, McDonough will help fulfill the company’s […]
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the completion of its Series C funding round, raising US$50m/£39m. […]
Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D PRINCETON, N.J. — Certara, a global leader in biosimulation, today announced the opening of a new office in Shanghai’s Pudong District, China’s epicenter for biopharmaceutical research and development (R&D). The office will allow Certara to strengthen its collaboration with customers […]
Collaboration across leading academic institutions and industry to create data coordinating center to advance understanding of Down syndrome and its co-occurring medical conditions BOSTON – Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced participation in the Data Management and Portal for INCLUDE (DAPI) Project, which will create a world class platform for data sharing, data access, and […]
Partnership with DNAnexus will enable 37 MDA Care Centers to analyze data from the MOVR Data Hub to better understand disease progression and compare outcomes across therapeutic categories New York — The Muscular Dystrophy Association (MDA) announced today the launch of the neuroMuscular ObserVational Research (MOVR) Visualization and Reporting Platform (VRP). The new platform represents […]
UK Resilience Project in COVID-19 co-led by Universities of Nottingham, Dundee, and Edinburgh, and Public Health England BC Platforms, a global leader in clinical and genomic data management, analytics and access, announced today that it has been appointed as data platform partner in a cross-UK project to enable research by connecting COVID-19 data derived from […]
QIAGEN launches QIAseq Human Exome TR Insights, a new integrated solution for Whole Exome Sequencing
• Novel Sample to Insight solution combines high-performance chemistry with robust bioinformatics, enabling researchers to sequence and analyze genomic variations across the entire human exome • Accelerates translational research of human diseases, especially rare and undiagnosed genetic diseases • Introduces high-performance hybrid capture enrichment technology to QIAGEN’s QIAseq NGS portfolio Hilden, Germany, and Germantown, Maryland […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
